Extending the golden hour to golden days.
A needle-free bandage you seal over a wound. Squeeze the bulb and a gentle current drives medication into the tissue — fighting infection, slowing bleeding, and easing pain right at the point of injury, to help extend the ‘golden hour.’
Core tech validated · TRL-6 Trauma bandage · TRL-3 / MRL-3

Seal it, and the medicine goes in — no needle.
Once the bandage is sealed, a gentle current takes over: charged medication is set in motion and carried straight through the skin into the wounded tissue — antimicrobial, clotting agent, or anesthetic, delivered where the injury is, without a single puncture.

A few disposable parts
Clinic-grade delivery, on the skin

Seal · activate · manage
Seal the bandage over the wound to stop bleeding and fluid loss. Activate — squeeze the bulb to deliver medication through the port while the bandage stays sealed, as multichannel iontophoresis drives it into the tissue. Manage the casualty with continuous treatment — extending the golden hour to golden days.
Simple, disposable production; clinic-grade treatment out — strong margins, a large unmet market, real human impact.

A bladder that closes the wound
On the underside, a conforming bladder presses down to seal the wound — stopping blood and fluid loss — while the two multichannel electrode wings lie flat against the tissue and deliver medication through the seal. One device stops the bleeding and treats.
From trials to the field
Validated core
The delivery core is pre-clinically validated at LSU (via the dental device) and sits at TRL-6; the trauma bandage itself is at TRL-3, seeking a development partner.
Target uses
Combat & field medicine, emergency care, dental, and chronic wounds — anywhere care is far away or a needle isn’t an option.
Federal grant track
Advancing under a submitted SBIR Phase I proposal for battlefield trauma care.
Regulatory path
Built on the FDA-cleared Medion iontophoresis predicate device.
Why it matters
Over 90% of battlefield deaths occur before reaching care; about 25% are survivable.
Design and layout per Henley Ion’s patent-pending iontophoretic wound-treatment device — US Pub. 2023/0036822 A1. TEK Bandage = Transdermal Electro-Kinetic Wound Bandage.
More time to save life, limb, and eyesight
The bandage is configuration- and medication-agnostic — the core transdermal technology integrates into any bandage platform and delivers whatever the situation calls for.
Care, sooner
Immediate access to higher-level medical care at the point of injury — antimicrobial to stop infection, a clotting agent to slow bleeding, or an anesthetic for pain, all while the wound stays sealed.
Time, extended
More time to save life, limb, and eyesight after a traumatic injury — turning the golden hour into golden days of continuous treatment.
Logistics, eased
Simpler mass-casualty medical-evacuation logistics — one lightweight, shelf-stable device that treats while it waits for transport.
Access to military-grade labs and testing, user feedback to custom-fit the core technology to existing field equipment, and R&D funding to reach the field. Download the one-pager (PDF) or get in touch.
Help take the Active Bandage to the field.
The delivery core is validated and patented. What it needs now is a partner to carry the trauma bandage from prototype to the point of injury.
Start a conversation →